Amiloride: Clinical Trials

12 trials of Amiloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 recruiting, 1 unknown. 12 Phase 2, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Completed 8, Recruiting 3, Unknown 1
Phase 34Completed 3, Unknown 1

Follow Amiloride: new trials by email Literature Review of Amiloride trials Research Report on Amiloride

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
ARX788, Computed Tomography (CT), Biospecimen Collection - HER2 Low Breast Carcinoma, Triple Negative Breast Cancer
Phase 2RecruitingLaura Huppert, MD, BA362026-06-052026-06-11
Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease
amiloride, Placebo - Chronic Kidney Disease(CKD), Proteinuria
Phase 2RecruitingOdense University Hospital402024-10-102025-04-11
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
Amiloride, Placebos - Migraine With Aura
Phase 2RecruitingCentre Hospitalier Universitaire de Nice402020-08-112025-12-04
ENAC Blockade and Arterial Stiffness
Placebo - Cap, Amiloride Pill - Overweight and Obesity, Insulin Resistance
Phase 2 / Phase 3CompletedUniversity of Missouri-Columbia1372019-07-152025-12-30
Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
Teriparatide, Thiazide, Potassium sparing diuretic - Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment
Phase 2CompletedAssistance Publique - Hôpitaux de Paris162017-06-062021-06-28
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
eplerenone, amiloride, Placebo - Primary Hyperparathyroidism
Phase 2 / Phase 3CompletedBrigham and Women's Hospital692016-01-012023-05-03
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
Spironolactone, Amiloride - Chronic Kidney Disease, Albuminuria
Phase 2CompletedUniversity of Alabama at Birmingham212015-03-012022-12-21
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Amiloride, Riluzole, Fluoxetine - Secondary Progressive Multiple Sclerosis
Phase 2CompletedUniversity College, London4452014-12-182020-03-26
Amiloride Clinical Trial In Optic Neuritis
Amiloride, Placebo - Optic Neuritis, Multiple Sclerosis
Phase 2CompletedUniversity of Oxford462013-02-012018-05-17
Novel Treatment for Coronary Artery Disease
Placebo, amiloride - Coronary Artery Disease
Phase 2 / Phase 3UnknownUniversity of Carabobo1002011-03-012013-03-19
Treatment of Coronary Heart Disease With Amiloride
Amiloride, Nitrates, clopidogrel, aspirin, statins - Coronary Heart Disease
Phase 2 / Phase 3CompletedUniversity of Carabobo702009-02-012012-06-11
Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis
7% NaCl, Amiloride HCl - Cystic Fibrosis
Phase 2CompletedUniversity of North Carolina242001-07-012006-01-10

Conditions studied

Renal Insufficiency, Chronic (2)  ·  Albuminuria (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Cystic Fibrosis (1)  ·  Epilepsy (1)  ·  Hypercalciuria (1)  ·  Hyperparathyroidism, Primary (1)  ·  Hypoparathyroidism (1)  ·  Insulin Resistance (1)  ·  Migraine Disorders (1)  ·  Migraine with Aura (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Obesity (1)

Sponsors

University of Carabobo (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Laura Huppert, MD, BA (1)  ·  Odense University Hospital (1)  ·  University College, London (1)  ·  University of Alabama at Birmingham (1)  ·  University of Missouri-Columbia (1)  ·  University of North Carolina (1)  ·  University of Oxford (1)

Countries

United States (5)  ·  France (2)  ·  United Kingdom (2)  ·  Venezuela (2)  ·  Denmark (1)

Top investigators

Antonio J Delgado-Leon, MD (2)  ·  Antonio R Delgado-Almeida, MD, FAHA, FACC, APS (2)  ·  Carlos L Delgado-Leon, MD (2)  ·  Agnes Linglart, MD, PhD (1)  ·  Anand Vaidya, MD MMSc (1)  ·  Anne Blanchard, MD, PhD (1)  ·  Camila Manrique Acevedo, MD (1)  ·  Jeremy Chataway (1)  ·  Laura Huppert, MD (1)  ·  Matthew Craner, MBChB PhD (1)  ·  Scott H. Donaldson, MD (1)  ·  Siddharthan Chandran (1)

Results publications

PMID 16450381, PMID 16611468, PMID 26553836, PMID 29172994, PMID 30166303, PMID 31981516, PMID 35945550, PMID 39262426

NIH funding

2016 (1)